Cellular Biomedicine Group Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.19 | $130.51 | 9.00% | 11 | $332.28B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | $118.92 | 21.53% | 7 | $181.08B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
| MDT | Medtronic | Outperform |
11
|
$85.92 | $92.47 | 11.73% | 9 | $114.09B |
| GSK | GSK | Outperform |
12
|
£17.75 | £17.30 | 12.39% | 12 | £72.39B |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $0.53M |
| 542765 | Transpact Enterprises | - |
0
|
361.00 | 0.00 | -100.00% | 0 | 139.61M |